KMYY(SH:600518)2017-04-27 16:00Financial Performance - Operating revenue for the period reached CNY 7.15 billion, a 21.56% increase year-on-year[6] - Net profit attributable to shareholders was CNY 1.07 billion, reflecting a 7.96% growth compared to the same period last year[6] - Basic earnings per share decreased by 3.56% to CNY 0.217[6] - The company's operating revenue for Q1 2017 was CNY 6,095,894,115.88, an increase of 13.5% compared to CNY 5,368,769,754.37 in the same period last year[32] - The net profit for Q1 2017 reached CNY 1,065,567,775.65, representing a growth of 8.1% from CNY 985,716,095.93 in Q1 2016[31] - The operating profit for the quarter was CNY 1,433,302,423.65, up 22.5% from CNY 1,170,337,827.73 year-over-year[31] - The total profit for the quarter was CNY 1,444,891,956.47, an increase of 22.9% compared to CNY 1,175,875,603.31 in Q1 2016[31] Cash Flow - Net cash flow from operating activities surged by 187.83% to CNY 1.35 billion[6] - The company reported a net cash flow from operating activities of CNY 1,349,526,864.40, significantly higher than CNY 468,865,025.85 in the previous year[34] - The net cash flow from operating activities for Q1 2017 was CNY 1,065,237,361.64, a significant increase from CNY 346,512,989.73 in the previous year, representing a growth of approximately 207%[38] - Total cash inflow from financing activities reached CNY 7,300,000,000.00, compared to CNY 1,500,000,000.00 in the same period last year, indicating a growth of 387%[38] - The net cash flow from financing activities surged by 526.48% to ¥1,721,038,446.03, mainly due to increased bond issuance[18] - The cash inflow from sales of goods and services was CNY 6,276,250,512.38, an increase from CNY 5,766,174,028.55, representing a growth of approximately 9%[37] Assets and Liabilities - Total assets increased by 6.57% to CNY 58.43 billion compared to the end of the previous year[6] - Total liabilities increased significantly, with other payables rising by 65.21% to ¥688,413,825.31, attributed to increased payable equity and other amounts[15] - Current liabilities rose to ¥22,765,915,002.31, compared to ¥20,024,441,417.91, marking an increase of 13.7%[24] - Total liabilities amounted to ¥28,184,304,421.04, up from ¥25,440,769,542.67, reflecting an increase of 10.8%[24] - Cash and cash equivalents reached ¥28,523,027,766.96, up from ¥26,188,373,690.67, indicating a growth of 8.9%[26] Shareholder Information - The total number of shareholders reached 133,830 at the end of the reporting period[10] - The largest shareholder, Kangmei Industrial Investment Holding Co., Ltd., holds 31.27% of the shares, amounting to 1.55 billion shares[10] - The total number of preferred shareholders at the end of the reporting period is 8[12] - The top ten preferred shareholders hold a total of 30% of the shares, with 博时基金－工商银行 holding 9,000,000 shares[13] - The company has not disclosed any other relationships among the top ten shareholders[14] Investments and Projects - The company has invested ¥1,774,904,329.49 in the Puning Chinese herbal medicine professional market project, exceeding the budget by 77.49%[17] - The company has budgeted ¥3,000,000,000.00 for the China-ASEAN Kangmei Yulin Chinese herbal medicine trading center project, with cumulative investment at ¥27,946,115.44, representing 0.93% of the budget[17] - Long-term equity investments rose by 89.72% to ¥843,509,641.13, primarily due to increased investments in jointly established industrial funds[15] Tax and Expenses - The company reported a 99.48% increase in income tax expenses to ¥379,324,180.82, reflecting growth in total profit and a corporate income tax rate of 25%[18] - The company reported a tax expense of CNY 379,324,180.82, which is a significant increase from CNY 190,159,507.38 in the same period last year[31] - Financial expenses increased to CNY 221,411,275.96 from CNY 144,771,584.66, reflecting a rise of 53% year-over-year[31]